Upside Biotechnologies appoints leading US life sciences executive to Board
Regenerative medicine start-up, Upside Biotechnologies, has appointed Boston-based Dr Daniel R. Marshak Ph.D. to its Board.
New Zealand-based Upside is developing an advanced, world-class skin replacement treatment for patients suffering major burns.
